These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3030317)

  • 1. A strong homology exists between the active T-cell binding gp120 octapeptide of human immunodeficiency virus and the subtilisin cleavage peptide of bovine ribonuclease A.
    Pincus MR; Carty RP; Chen J; Murphy RB
    Biochem Biophys Res Commun; 1987 Feb; 143(1):248-51. PubMed ID: 3030317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative X-ray crystallographic evidence for a beta-bend conformation as the active structure for peptide T in T4 receptor recognition.
    Chen J; Barber A; Pedersen J; Brandt-Rauf PW; Carucci J; Murphy RB; Carty RP; Licht D; Pincus MR
    J Protein Chem; 1989 Feb; 8(1):87-100. PubMed ID: 2548525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIP1-12 is a ligand for the CD4/human immunodeficiency virus receptor.
    Sacerdote P; Ruff MR; Pert CB
    Ann N Y Acad Sci; 1988; 527():574-8. PubMed ID: 2839089
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of the conformation of a modified ribonuclease octapeptide, homologous to peptide T, with its ability to induce CD4-dependent monocyte chemotaxis.
    Licht D; Cronstein B; Dykes DC; Pedersen J; Luster SM; Trampota M; Hull E; Friedman FK; Pincus MR
    J Protein Chem; 1992 Oct; 11(5):475-81. PubMed ID: 1449597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.
    Jameson BA; Rao PE; Kong LI; Hahn BH; Shaw GM; Hood LE; Kent SB
    Science; 1988 Jun; 240(4857):1335-9. PubMed ID: 2453925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nanopeptide from HTLV-III, ARV-2 and LAVBRU envelope gp120 determining binding to T4 cell surface protein.
    Veljković V; Metlas R
    Cancer Biochem Biophys; 1988 Nov; 10(2):91-106. PubMed ID: 2855309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
    Berger EA; Fuerst TR; Moss B
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity.
    Pert CB; Hill JM; Ruff MR; Berman RM; Robey WG; Arthur LO; Ruscetti FW; Farrar WL
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9254-8. PubMed ID: 3097649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK; Sieh M; Pious DA; Reinherz EL
    Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor.
    Nygren A; Bergman T; Matthews T; Jörnvall H; Wigzell H
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6543-6. PubMed ID: 2842778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessibility of the highly conserved amino- and carboxy-terminal regions from HIV-1 external envelope glycoproteins.
    Bahraoui E; Clerget-Raslain B; Granier C; Van Rietschoten J; Sabatier JM; Labbé-Julie C; Ceard B; Rochat H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1989 Aug; 5(4):451-63. PubMed ID: 2548546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.
    Cease KB; Margalit H; Cornette JL; Putney SD; Robey WG; Ouyang C; Streicher HZ; Fischinger PJ; Gallo RC; DeLisi C
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4249-53. PubMed ID: 2438696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
    Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
    Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guest-host crosstalk in an angiogenin-RNase A chimeric protein.
    Holloway DE; Shapiro R; Hares MC; Leonidas DD; Acharya KR
    Biochemistry; 2002 Aug; 41(33):10482-9. PubMed ID: 12173935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
    Kowalski M; Ardman B; Basiripour L; Lu YC; Blohm D; Haseltine W; Sodroski J
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3346-50. PubMed ID: 2541442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
    Farrar WL; Harel-Bellan A; Ferris DK
    Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.